BRIVIACT sol inj 50 mg/5ml 10 flac 5 ml
7680658300016
CH-65830
N03AX23
01.07.1.
1 / 3
google
Details
- Product number
- 6583001
- CPT
- -
- Packaging group
- 10
- Unit
- Durchstechflasche(n)
- Composition
- brivaracetamum 50 mg, natrii chloridum, natrii acetas trihydricus, acidum aceticum q.s. ad pH, aqua ad iniectabile ad solutionem pro 5 ml corresp. natrium 19.0875 mg.
Articles (1)
Briviact 50 mg/5 ml, solution injectable
Injektionslösung
10
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
19.0875 MG | Substance | HBESI |
Authorization holder
UCB-Pharma SA
1630 Bulle
Authorization information
- Swissmedic authorization number
- 65830
- Drug name
- Briviact, solution injectable
- Galenic form
- LSPA
- ATC Code
- N03AX23
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 06/10/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 01.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BRIVIACT sol inj 50 mg/5ml 10 flac 5 ml
- Description (DE)
- BRIVIACT Inj Lös 50 mg/5ml 10 Durchstf 5 ml
- Market launch
- 06/10/2016
- Narcotic (BTM)
- No